Intervention Protocol

You have free access to this content

Intra-arterial chemotherapy for high-grade gliomas

  1. Xian Tao Zeng1,
  2. Wei Jing Bi2,*,
  3. Ping Li2,
  4. Ai Ping Deng3,
  5. Li Zhang3,
  6. Yan Chu Li2,
  7. Zhiyong Dong4

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 6 JUN 2013

DOI: 10.1002/14651858.CD010549

How to Cite

Zeng XT, Bi WJ, Li P, Deng AP, Zhang L, Li YC, Dong Z. Intra-arterial chemotherapy for high-grade gliomas (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010549. DOI: 10.1002/14651858.CD010549.

Author Information

  1. 1

    Taihe Hospital, Hubei University of Medicine, Department of Stomatology, Shiyan, Hubei, China

  2. 2

    Sichuan University, The Department of Head, Neck and Breast Oncology, Cancer Center, West China Hospital; The State Key Laboratory of Biotherapy, Chengdu, Sichuan, China

  3. 3

    Taihe Hospital, Hubei University of Medicine, Department of Neurosurgery, Shiyan, Hubei, China

  4. 4

    The First Affiliated Hospital of Guangxi Medical University, Hepato-Pancreato-Biliary Surgery, Nanning, Guangxi, China

*Wei Jing Bi, The Department of Head, Neck and Breast Oncology, Cancer Center, West China Hospital; The State Key Laboratory of Biotherapy, Sichuan University, Wai Nan Guo Xue Line, No.37, Chengdu, Sichuan, 610041, China.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 6 JUN 2013



Additional references

Basso 2002
  • Basso U, Lonardi S, Brandes AA. Is intra-arterial chemotherapy useful in high-grade gliomas?. Expert review of anticancer therapy 2002;2(5):507-19. [PUBMED: 12382519]
Bredel 1997
  • Bredel M, Pollack IF, Campbell JW, Hamilton RL. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas. Clinical Cancer Research 1997;3(11):2157-64. [PUBMED: 9815610]
Bucher 1997
  • Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
Christensen 2011
  • Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, et al. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. Journal of the National Cancer Institute 2011;103(2):143-53.
Counsell 1996
Croteau 2001
  • Croteau D, Mikkelsen T. Adults with newly diagnosed high-grade gliomas. Current Treatment Options in Oncology 2001;2(6):507-15. [PUBMED: 12057096]
CTCAE v4.0
  • National Cancer Institute at the National Institutes of Health. Common Terminology Criteria for Adverse Events. Version 4.0. May 28, 2009 and revised June 14 2010.
Davis 1998
  • Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. Journal of Neurosurgery 1998;88(1):1-10. [PUBMED: 9420066]
Deeks 2001
  • Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
DerSimonian 1986
Desjardins 2005
  • Desjardins A, Rich JN, Quinn JA, Vredenburgh J, Gururangan S, Sathornsumetee S, et al. Chemotherapy and novel therapeutic approaches in malignant glioma. Frontiers in Bioscience 2005;10:2645-68. [PUBMED: 15970525]
Emerich 2000
  • Emerich DF, Winn SR, Snodgrass P, LaFreniere D, Agostino M, Wiens T, et al. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors. Pharmaceutical Research 2000;17(7):776-81. [PUBMED: 10990194]
GRADEpro 2008 [Computer program]
  • Brozek J, Oxman A, Schünemann H. GRADEpro. Version 3.2 for Windows. Brozek J, Oxman A, Schünemann H, 2008.
Grant 2004
  • Grant R. Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines. Journal of Neurology, Neurosurgery, and Psychiatry 2004;75 Suppl 2:ii18-23. [PUBMED: 15146035]
Hiesiger 1995
  • Hiesiger EM, Green SB, Shapiro WR, Burger PC, Selker RG, Mahaley MS Jr, et al. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A. Journal of Neuro-oncology 1995;25(2):143-54. [PUBMED: 8543970]
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from
Imbesi 2006
  • Imbesi F, Marchioni E, Benericetti E, Zappoli F, Galli A, Corato M, et al. A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas. Anticancer Research 2006;26(1B):553-8. [PUBMED: 16739319]
Kleihues 1993
Louis 2007
  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007;114(2):97-109. [PUBMED: 17618441]
Newton 2005
  • Newton HB. Intra-arterial chemotherapy of primary brain tumors. Current Treatment Options in Oncology 2005;6(6):519-30. [PUBMED: 16242056]
Neyns 2010
  • Neyns B, D'haeseleer M, Rogiers A, Van de Cauter J, Chaskis C, Michotte A, et al. The role of cytotoxic drugs in the treatment of central nervous system gliomas. Acta Neurologica Belgica 2010;110(1):1-14. [PUBMED: 20514922]
Parmar 1998
Reddy 2003
Rooney 2011
  • Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. Journal of the National Cancer Institute 2011;103(1):61-76. [PUBMED: 21106962]
Shapiro 1992
  • Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. Journal of Neurosurgery 1992;76(5):772-81. [PUBMED: 1564540]
Storstein 2011
  • Storstein A, Helseth E, Johannesen TB, Schellhorn T, Mork S, van Helvoirt R. [High-grade gliomas in adults [Hoygradige gliomer hos voksne]. Tidsskrift for den Norske Laegeforening 2011;131(3):238-41. [PUBMED: 21304572]
Stupp 2005
  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine 2005;352(10):987-96.
Tierney 2007
Wen 2010
  • Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteriain high grade gliomas: response assessment in neuro-oncology working group. Journal of Clinical Oncology 2010;28(11):1963-72.